MF
Marsha Fanucci
Director

Marsha Fanucci insider trades: Alnylam Pharmaceuticals (ALNY) stock buys and sales

Director, Alnylam Pharmaceuticals Last trade Nov 20, 2019 74 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2006
8
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Marsha reports to the SEC

and 2 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 20, 2019ALNY↓ Sell$7.5M
Mar 18, 2015IRWD↓ Sell$491K
Feb 25, 2015ALNY↓ Sell$1.1M
Mar 15, 2013MNTA↓ Sell$416K
Feb 21, 2012ALNY↑ Buy$108K
Feb 2, 2010IRWD↑ Buy$248K
Mar 11, 2008MLNM↓ Sell$137K
Feb 29, 2008MLNM↓ Sell$75K
Sep 19, 2007MLNM↓ Sell$186K
Mar 12, 2007MLNM↓ Sell$109K
Feb 6, 2007MLNM↓ Sell$84K
Sep 18, 2006MLNM↓ Sell$110K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ALNY insiders

Open-market trades in the last 12 months

About Marsha Fanucci's insider trades

Marsha Fanucci is a director at Alnylam Pharmaceuticals (ALNY). Since Sep 18, 2006, Marsha has reported 2 open-market purchases worth $355K and 10 sales worth $10.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (55 filings), option exercises (3 filings), shares returned to the company (3 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALNY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.